Original Research

Published on 17 May 2021

PD-1-Positive Tumor-Associated Macrophages Define Poor Clinical Outcomes in Patients With Muscle Invasive Bladder Cancer Through Potential CD68/PD-1 Complex Interactions

in Cancer Immunity and Immunotherapy

Li-Ren Jiang
Ning Zhang
Si-Teng Chen
Jin He
Yong-Hua Liu
Ya-Qin Han
Xiao-Qin Shi
Ji-Ji Yang
Dong-Yun Mu
Guo-Hui Fu

Frontiers in Oncology

doi 10.3389/fonc.2021.679928

5,331 views
15 citations

Original Research

Published on 14 May 2021

A Novel CAR Expressing NK Cell Targeting CD25 With the Prospect of Overcoming Immune Escape Mechanism in Cancers

in Cancer Immunity and Immunotherapy

Moein Dehbashi
Zohreh Hojati
Majid Motovali-bashi
Mohamad Reza Ganjalikhany
William C. Cho
Akihiro Shimosaka
Parnian Navabi
Mazdak Ganjalikhani-Hakemi

Frontiers in Oncology

doi 10.3389/fonc.2021.649710

10,649 views
19 citations

Original Research

Published on 13 May 2021

Characterization of the Immune Cell Infiltration Profile in Pancreatic Carcinoma to Aid in Immunotherapy

in Cancer Immunity and Immunotherapy

De Luo
Fei Kuang
Juan Du
Mengjia Zhou
Fangyi Peng
Yu Gan
Cheng Fang
Xiaoli Yang
Bo Li
Song Su

Frontiers in Oncology

doi 10.3389/fonc.2021.677609

4,017 views
7 citations

Review

Published on 13 May 2021

Repurposing Infectious Diseases Vaccines Against Cancer

in Cancer Immunity and Immunotherapy

Liese Vandeborne
Pan Pantziarka
An M. T. Van Nuffel
Gauthier Bouche

Frontiers in Oncology

doi 10.3389/fonc.2021.688755

10,171 views
26 citations

Systematic Review

Published on 11 May 2021

A Comparison Between Chemo-Radiotherapy Combined With Immunotherapy and Chemo-Radiotherapy Alone for the Treatment of Newly Diagnosed Glioblastoma: A Systematic Review and Meta-Analysis

in Cancer Immunity and Immunotherapy

Montserrat Lara-Velazquez
Jack M. Shireman
Eric J. Lehrer
Kelsey M. Bowman
Henry Ruiz-Garcia
Mitchell J. Paukner
Richard J. Chappell
Mahua Dey

Frontiers in Oncology

doi 10.3389/fonc.2021.662302

5,347 views
12 citations

Review

Published on 10 May 2021

Making a Cold Tumor Hot: The Role of Vaccines in the Treatment of Glioblastoma

in Cancer Immunity and Immunotherapy

Stephen C. Frederico
John C. Hancock
Emily E. S. Brettschneider
Nivedita M. Ratnam
Mark R. Gilbert
Masaki Terabe

Frontiers in Oncology

doi 10.3389/fonc.2021.672508

15,657 views
66 citations

Original Research

Published on 10 May 2021

Analysis of Autophagy-Related Signatures Identified Two Distinct Subtypes for Evaluating the Tumor Immune Microenvironment and Predicting Prognosis in Ovarian Cancer

in Cancer Immunity and Immunotherapy

Xingyu Chen
Hua Lan
Dong He
Zhanwang Wang
Runshi Xu
Jing Yuan
Mengqing Xiao
Yao Zhang
Lian Gong
Songshu Xiao

Frontiers in Oncology

doi 10.3389/fonc.2021.616133

4,929 views
18 citations

Review

Published on 07 May 2021

Targeting DNA Damage Repair for Immune Checkpoint Inhibition: Mechanisms and Potential Clinical Applications

in Cancer Immunity and Immunotherapy

Wei Sun
Qing Zhang
Runkun Wang
Yang Li
Yue Sun
Lin Yang

Frontiers in Oncology

doi 10.3389/fonc.2021.648687

8,398 views
37 citations

Case Report

Published on 07 May 2021

Case Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment for Recurrent Glioblastoma

in Cancer Immunity and Immunotherapy

Joseph S. Durgin
Fraser Henderson
MacLean P. Nasrallah
Suyash Mohan
Sumei Wang
Simon F. Lacey
Jan Joseph Melenhorst
Arati S. Desai
John Y. K. Lee
Marcela V. Maus

Frontiers in Oncology

doi 10.3389/fonc.2021.669071

10,601 views
49 citations

Original Research

Published on 05 May 2021

IL-21 Is an Accomplice of PD-L1 in the Induction of PD-1-Dependent Treg Generation in Head and Neck Cancer

in Cancer Immunity and Immunotherapy

Yi Zhao
Zhiyu Zhang
Wenbin Lei
Yi Wei
Renqiang Ma
Yihui Wen
Fanqin Wei
Jun Fan
Yang Xu
Lin Chen

Frontiers in Oncology

doi 10.3389/fonc.2021.648293

4,668 views
12 citations

Case Report

Published on 30 Apr 2021

Case Report: A Case of Trimethoprim/Sulfamethoxazole-Triggered Hypotensive Shock: Cytokine Release Syndrome Related to Immune Checkpoint Inhibitors and Drug-Induced Hypersensitivity Syndrome

in Cancer Immunity and Immunotherapy

Tetsuya Urasaki
Makiko Ono
Toshiaki Mochizuki
Koichi Takeda
Aya Nishizawa
Eri Fukagawa
Motohiro Fujiwara
Yoshinobu Komai
Shigehisa Kitano
Takeshi Yuasa

Frontiers in Oncology

doi 10.3389/fonc.2021.681997

5,655 views
14 citations

Review

Published on 29 Apr 2021

Beyond Tumor Mutation Burden: Tumor Neoantigen Burden as a Biomarker for Immunotherapy and Other Types of Therapy

in Cancer Immunity and Immunotherapy

Peipei Wang
Yueyun Chen
Chun Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.672677

12,494 views
73 citations

Review

Published on 29 Apr 2021

Strategies for the Construction of Mouse Models With Humanized Immune System and Evaluation of Tumor Immune Checkpoint Inhibitor Therapy

in Cancer Immunity and Immunotherapy

Wenwen Guo
Caiqin Zhang
Tianyun Qiao
Jumei Zhao
Changhong Shi

Frontiers in Oncology

doi 10.3389/fonc.2021.673199

5,493 views
9 citations

Case Report

Published on 29 Apr 2021

Anti-PD-1 Immunotherapy and Bee Venom for Relapsed and Refractory Liposarcoma: A Case Report

in Cancer Immunity and Immunotherapy

Wei Yang
Yeke Zhang
Gaoyi Yang
Yanhua Geng
Da Chen
Jun Wang
Yang Ye
Huaichong Wang
Dajing Xia
Fuliang Hu

Frontiers in Oncology

doi 10.3389/fonc.2021.668992

8,517 views
3 citations

Original Research

Published on 29 Apr 2021

Cancer Cell B7-H3 Expression Is More Prevalent in the Pancreato-Biliary Subtype of Ampullary Cancer Than in Pancreatic Cancer

in Cancer Immunity and Immunotherapy

Emma E. Geerdes
Kostandinos Sideras
M. Hosein Aziz
Casper H. van Eijck
Marco J. Bruno
Dave Sprengers
Patrick P. C. Boor
Jaap Kwekkeboom

Frontiers in Oncology

doi 10.3389/fonc.2021.615691

4,038 views
6 citations

Original Research

Published on 29 Apr 2021

Alternative Splicing Events in Tumor Immune Infiltration in Colorectal Cancer

in Cancer Immunity and Immunotherapy

Jian-yu Shi
Yan-yan Bi
Bian-fang Yu
Qing-feng Wang
Dan Teng
Dong-ning Wu

Frontiers in Oncology

doi 10.3389/fonc.2021.583547

5,085 views
12 citations

Navigation group

Articles

PD-1-Positive Tumor-Associated Macrophages Define Poor Clinical Outcomes in Patients With Muscle Invasive Bladder Cancer Through Potential CD68/PD-1 Complex Interactions

A Novel CAR Expressing NK Cell Targeting CD25 With the Prospect of Overcoming Immune Escape Mechanism in Cancers

Characterization of the Immune Cell Infiltration Profile in Pancreatic Carcinoma to Aid in Immunotherapy

Repurposing Infectious Diseases Vaccines Against Cancer

A Comparison Between Chemo-Radiotherapy Combined With Immunotherapy and Chemo-Radiotherapy Alone for the Treatment of Newly Diagnosed Glioblastoma: A Systematic Review and Meta-Analysis

Making a Cold Tumor Hot: The Role of Vaccines in the Treatment of Glioblastoma

Analysis of Autophagy-Related Signatures Identified Two Distinct Subtypes for Evaluating the Tumor Immune Microenvironment and Predicting Prognosis in Ovarian Cancer

Targeting DNA Damage Repair for Immune Checkpoint Inhibition: Mechanisms and Potential Clinical Applications

Case Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment for Recurrent Glioblastoma

IL-21 Is an Accomplice of PD-L1 in the Induction of PD-1-Dependent Treg Generation in Head and Neck Cancer

Case Report: A Case of Trimethoprim/Sulfamethoxazole-Triggered Hypotensive Shock: Cytokine Release Syndrome Related to Immune Checkpoint Inhibitors and Drug-Induced Hypersensitivity Syndrome

Beyond Tumor Mutation Burden: Tumor Neoantigen Burden as a Biomarker for Immunotherapy and Other Types of Therapy

Strategies for the Construction of Mouse Models With Humanized Immune System and Evaluation of Tumor Immune Checkpoint Inhibitor Therapy

Anti-PD-1 Immunotherapy and Bee Venom for Relapsed and Refractory Liposarcoma: A Case Report

Cancer Cell B7-H3 Expression Is More Prevalent in the Pancreato-Biliary Subtype of Ampullary Cancer Than in Pancreatic Cancer

Alternative Splicing Events in Tumor Immune Infiltration in Colorectal Cancer